Kopran Limited has informed the Exchange about Amalgamation/Merger
KOPRAN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Kopran Limited has provided an update on the Scheme of Amalgamation where Kopran Laboratories Limited (Transferor Company) will merge into Kopran Limited (Transferee Company). The NCLT Mumbai Bench, through its order dated April 9, 2026, has directed both companies to convene meetings for Equity Shareholders, Secured Creditors, and Unsecured Creditors. This is a standard procedural step in the merger approval process under Section 230 to 232 of the Companies Act, 2013. The merger remains subject to applicable regulatory and other approvals.
This is a positive development as the merger moves forward with NCLT oversight. Shareholders should monitor the upcoming creditor and shareholder meetings as their approval will be required for the scheme to proceed. No immediate impact on stock price expected until the deal closes.